Publications

1. Estey MP, Diamandis EP, Van Straeten CD, Tower SS, Hart AJ, Moyer TP. Cobalt and chromium measurement in patients with metal hip prostheses. Clin Chem. 2013; 59(6):880-6. 2329854
   
2. Coats D, Shelton-Dodge K, Ou K, Khun V, Seab S, Sok K, Prou C, Tortorelli S, Moyer TP, Cooper LE, Begley TP, Enders F, Fischer PR, Topazian M. Thiamine deficiency in Cambodian infants with and without beriberi. J Pediatr. 2012 Nov; 161(5):843-7. Epub 2012 Jun 14. 2284148
   View PubMed
3. Schmitt BH, Feder MT, Rokke DL, Moyer TP, Pritt BS. An unusual foreign body in the urinary bladder mimicking a parasitic worm. J Clin Microbiol. 2012 Jul; 50(7):2520-2. Epub 2012 Apr 25 2240727
   View PubMed
4. Estey MP, Diamandis EP, Van Der Straeten C, Tower SS, Hart AJ, Moyer TP. Cobalt and Chromium Measurement in Patients with Metal Hip Prostheses. Clinical Chemistry (. 2012; In Press). 2258138
   
5. Moyer TP, Highsmith WE, Smyrk TC, Gross JB Jr. Hereditary hemochromatosis: laboratory evaluation. Clin Chim Acta. 2011 Aug 17; 412(17-18):1485-92. Epub 2011 Apr 13. 2159696
   View PubMed
6. Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011 Mar 1; 52(5):604-11. Epub 2011 Jan 16. 2147077
   View PubMed
7. McAlpine DE, Biernacka JM, Mrazek DA, O'Kane DJ, Stevens SR, Langman LJ, Courson VL, Bhagia J, Moyer TP. Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine. Ther Drug Monit. 2011 Feb; 33(1):14-20. 2125545
   View PubMed
8. Christensen KN, Lee CU, Hanley MM, Leung N, Moyer TP, Pittelkow MR. Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis. J Am Acad Dermatol. 2011 Jan; 64(1):91-6. Epub 2010 Oct 30. 2123989
   View PubMed
9. Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study). J Am Coll Cardiol. 2010 Jun 22; 55(25):2804-12. Epub 2010 Apr 08. 2105292
   View PubMed
10. Moyer TP, O'Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, Dupras DM, Chaudhry R, Thapa P, Zinsmeister AR, Heit JA. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Mayo Clin Proc. 2009 Dec; 84(12):1079-94. 1975565
    View PubMed
11. Leung N, Pittelkow MR, Lee CU, Good JA, Hanley MM, Moyer TP. Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis. Nephrology Dialysis Transplantation (NDT Plus) 2009; 2:309-11. 1991451
    
12. Wilkins BW, Hesse C, Charkoudian N, Nicholson WT, Sviggum HP, Moyer TP, Joyner MJ, Eisenach JH. Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade. Clin Pharmacol Ther. 2008 May; 83(5):692-701. Epub 2007 Aug 08. 1874198
    View PubMed
13. Ebbert JO, Post JA, Moyer TP, Dale LC, Schroeder DR, Hurt RD. Nicotine percentage replacement among smokeless tobacco users with nicotine patch. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):223-6. Epub 2007 Feb 14. 1830792
    View PubMed
14. Wilkins BW, Hesse C, Sviggum HP, Nicholson WT, Moyer TP, Joyner MJ, Eisenach JH. Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. Clin Auton Res. 2007 Apr; 17(2):77-84. Epub 2006 Dec 11. 1822430
    View PubMed
15. Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Nicotine Tob Res. 2007 Jan; 9(1):43-52. 1807210
    View PubMed
16. Woodworth A, Saunders AN, Koenig JW, Moyer TP, Turk J, Dietzen DJ. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. Clin Chem. 2006 Apr; 52(4):743-6. Epub 2006 Feb 02. 1757074
    View PubMed
17. Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, Provost EM. Iqmik: A form of smokeless tobacco used among Alaska Natives. Am J Health Behav. 2005 Nov-Dec; 29(6):588-94. 1748528
    View PubMed
18. Hurt RD, Renner CC, Patten CA, Ebbert JO, Offord KP, Schroeder DR, Enoch CC, Gill L, Angstman SE, Moyer TP. Iqmik - A form of smokeless tobacco used by pregnant Alaska natives: Nicotine exposure in their neonates. Journal of Maternal-Fetal & Neonatal Medicine. 2005 Apr; 17(4):281-9. 1729779
    View PubMed
19. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol. 2005 Jan; 123(1):146-52. 1677917
    View PubMed
20. Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt R. Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users. Addict Behav. 2004 Feb; 29(2):349-55. 1639173
    View PubMed
21. Wu AHB, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P. National academy of clinical biochemistry laboratory medicine practice guidelines: Recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003 Mar; 49(3):357-79. 1319002
    View PubMed
22. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem. 2002 Sep; 48(9):1460-71. 1315222
    View PubMed
23. Schroeder DR, Ogburn PL Jr, Hurt RD, Croghan IT, Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes. J Matern Fetal Neonatal Med. 2002 Feb; 11(2):100-7. 1641176
    View PubMed
24. Roberts WL, Annesley TM, De BK, Moulton L, Juenke JM, Moyer TP. Performance characteristics of four free phenytoin immunoassays. Ther Drug Monit. 2001 Apr; 23(2):148-54. 1004769
    View PubMed
25. Ogburn P, Ramin K, Schroeder D, Hurt R, Croghan I, Offord K, Moyer T. Long term nicotine patch use in pregnancy: safety and effectiveness. Am J Obstet Gynecol. 2001; 185(6):S120. 1817834
    
26. Clouse WD, Yamaguchi H, Phillips MR, Hurt RD, Fitzpatrick LA, Moyer TP, Rowland C, Schaff HV, Miller VM. Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts. J Appl Physiol. 2000 Sep; 89(3):1213-23. 137168
    View PubMed
27. Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000 Jul 1; 96(1):76-9. 1013105
    View PubMed
28. Hurt RD, Ahlskog JE, Croghan GA, Offord KP, Wolter TD, Croghan IT, Moyer TP. Carbidopa/levodopa for smoking cessation: a pilot study with negative results. Nicotine & Tobacco Research. 2000; 2:71-8. 142422
    View PubMed
29. Ogburn PL Jr, Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol. 1999 Sep; 181(3):736-43. 1009259
    View PubMed
30. Moyer TP, Temesgen Z, Enger R, Estes L, Charlson J, Oliver L, Wright A. Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study. Clin Chem. 1999 Sep; 45(9):1465-76. 1009485
    View PubMed
31. Nixon DE, Burritt MF, Moyer TP. The determination of mercury in whole blood and urine by inductively coupled plasma mass spectrometry. Spectrochim Acta B. 1999 Aug 9; 54(8):1141-53. 1011091
    
32. Nixon DE, Moyer TP, Burritt MF. The determination of selenium in serum and urine by inductively coupled plasma mass spectrometry: comparison with Zeeman graphite furnace atomic absorption spectrometry. Spectrochim Acta B. 1999 Jun 14; 54(6):931-42. 117609
    
33. Pettersen MD, Driscoll DJ, Moyer TP, Dearani JA, McGregor CG. Measurement of blood serum cyclosporine levels using capillary "fingerstick" sampling: a validation study. Transpl Int. 1999; 12(6):429-32. 1010008
    View PubMed
34. Hurt RD, Offord KP, Croghan IT, Croghan GA, Gomez-Dahl LC, Wolter TD, Dale LC, Moyer TP. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology (Berl) 1998 Nov; 140(1):98-104. 108593
    View PubMed
35. Weinzweig J, Schnur PL, McConnell JP, Harris JB, Petty PM, Moyer TP, Nixon D. Silicon analysis of breast and capsular tissue from patients with saline or silicone gel breast implants: II. Correlation with connective-tissue disease. Plastic & Reconstructive Surgery. 1998 Jun; 101(7):1836-41. 1021089
    View PubMed
36. Moyer TP, Oliver LK. Supporting pharmaceutical studies for FDA submissions: diversifying the drug monitoring laboratory. Clin Chem. 1998 Feb; 44(2):433-6. 1021070
    View PubMed
37. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 1997 Mar; 112(3):882-8. 1015943
    View PubMed
38. McConnell JP, Moyer TP, Nixon DE, Schnur PL, Salomao DR, Crotty TB, Weinzweig J, Harris JB, Petty PM. Determination of silicon in breast and capsular tissue from patients with breast implants performed by inductively coupled plasma emission spectroscopy. Comparison with tissue histology. Am J Clin Pathol. 1997 Feb; 107(2):236-46. 1018282
    View PubMed
39. Schnur PL, Weinzweig J, Harris JB, Moyer TP, Petty PM, Nixon D, McConnell JP. Silicon analysis of breast and periprosthetic capsular tissue from patients with saline or silicone gel breast implants. Plast Reconstr Surg. 1996 Oct; 98(5):798-803. 1015296
    View PubMed
40. Nixon DE, Moyer TP. Routine clinical determination of lead, arsenic, cadmium, and thallium in urine and whole blood by inductively coupled plasma mass spectrometry. Spectrochim Acta B. 1996 Jan 15; 51(1):13-25. 1026069
    
41. Fleming CR, George L, Stoner GL, Tarrosa VB, Moyer TP. The importance of urinary magnesium values in patients with gut failure. Mayo Clin Proc. 1996 Jan; 71(1):21-4. 1025051
    View PubMed
42. Nixon DE, Mussmann GV, Moyer TP. Inorganic, organic, and total mercury in blood and urine: cold vapor analysis with automated flow injection sample delivery. J Anal Toxicol. 1996 Jan-Feb; 20(1):17-22. 1015290
    View PubMed
43. Ho J, Moyer TP, Phillips SF. Chronic diarrhea: the role of magnesium. Mayo Clin Proc. 1995 Nov; 70(11):1091-2. 94250
    View PubMed
44. Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Guamanian neurodegenerative disease - investigation of the calcium metabolism heavy metal hypothesis. Neurology. 1995 Jul; 45:1340-4. 93117
    View PubMed
45. Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1995 Apr; 80(4):1376-81. 92210
    View PubMed
46. Bush VJ, Moyer TP, Batts KP, Parisi JE. Essential and toxic element concentrations in fresh and formalin-fixed autopsy tissues. Clin Chem. 1995 Feb; 41:284-294. 1023254
    View PubMed
47. Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol. 1994 Oct; 102(4):443-6. 1032579
    View PubMed
48. Ludwig J, Batts KP, Moyer TP, Poterucha JJ. Advances in liver biopsy diagnosis. Mayo Clin Proc. 1994 Jul; 69(7):677-8. 88466
    View PubMed
49. Moyer TP. Testing for arsenic. Mayo Clin Proc. 1993 Dec; 68(12):1210-1. 1031296
    View PubMed
50. Morgenstern BZ, Milliner DS, Murphy ME, Simmons PS, Moyer TP, Wilson DM, Smith LH. Urinary oxalate and glycolate excretion patterns in the first year of life: a longitudinal study. J Pediatr. 1993 Aug; 123(2):248-51. 84324
    View PubMed
51. Lieberman N, Plevak D, Moyer T, Rettke S, Raasch R, Southorn P. Is it important to measure magnesium concentrations during and immediately after liver transplantation? Transplant Proc. 1993 Apr; 25(2):1826-7. 83392
    View PubMed
52. Ludwig J, Batts KP, Moyer TP, Baldus WP, Fairbanks VF. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. Mayo Clin Proc. 1993 Mar; 68(3):263-7. 1028876
    View PubMed
53. Herkes GK, Eadie MJ, Sharbrough FW, Moyer TP. Patterns of seizure occurrence in catamenial epilepsy. Epilepsy Research. 1993; 15:47-52. 1217444
    View PubMed
54. Nixon DE, Moyer TP. Arsenic analysis II: rapid separation and quantification of inorganic arsenic plus metabolites and arsenobetaine from urine. Clin Chem. 1992 Dec; 38(12):2479-83. 1028277
    View PubMed
55. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem. 1991 Sep; 37(9):1575-9. 1037765
    View PubMed
56. Hayes SN, Moyer TP, Morley D, Bove AA. Intravenous cocaine causes epicardial coronary vasoconstriction in the intact dog. Am Heart J. 1991 Jun; 121(6 Pt 1):1639-48. 76613
    View PubMed
57. Moyer TP, Winkels J, Krom R, Wiesner R. Evaluation of Abbott TDx monoclonal assay of cyclosporine in whole blood. Clin Chem. 1991 Jun; 37(6):1120-1. 78689
    View PubMed
58. Moyer TP, Mussmann GV, Nixon DE. Blood-collection device for trace and ultra-trace metal specimens evaluated. Clin Chem. 1991 May; 37(5):709-14. 1038364
    View PubMed
59. McCarthy JT, Hodgson SF, Fairbanks VF, Moyer TP. Clinical and histologic features of iron-related bone disease in dialysis patients. Am J Kidney Dis. 1991 May; 17(5):551-61. 78632
    View PubMed
60. Zachariah PK, Moyer TP, Theobald HM, Frantz RP, Kurtz SB, McCarthy JT, Smith RL. The pharmacokinetics of racemic verapamil in patients with impaired renal function. J Clin Pharmacol. 1991 Jan; 31(1):45-53. 75772
    View PubMed
61. Kachel DL, Moyer TP, Martin WJ 2nd. Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherol. Journal of Pharmacology & Experimental Therapeutics. 1990 Sep; 254(3):1107-12. 1035248
    View PubMed
62. Martin RW, Duffy J, Engel AG, Lie JT, Bowles CA, Moyer TP, Gleich GJ. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med. 1990 Jul 15; 113(2):124-34. 1313611
    View PubMed
63. Nelson PE, Moyer TP, Thistle JL. Gallstone dissolution in vitro using methyl tert-butyl ether: radiologic selection criteria. Gastroenterology. 1990 May; 98(5 Pt 1):1280-3. 1047936
    View PubMed
64. Nelson PE, Moyer TP, Thistle JL. Dissolution of calcium bilirubinate and calcium carbonate debris remaining after methyl tert-butyl ether dissolution of cholesterol gallstones. Gastroenterology. 1990 May; 98(5 Pt 1):1345-50. 1047937
    View PubMed
65. Moyer TP, et al. Consensus Document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine. Transplantation Proceedings. 1990; 22(3):1357-61. 1217443
    View PubMed
66. Nixon DE, Moyer TP, Squillace DP, McCarthy JT. Determination of serum nickel by graphite furnace atomic absorption spectrometry with Zeeman-effect background correction: values in a normal population and a population undergoing dialysis. Analyst. 1989 Dec; 114(12):1671-4. 1046306
    View PubMed
67. McCarthy JT, Johnson WJ, Nixon DE, Jenson BM, Moyer TP. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. J Lab Clin Med. 1989 Aug; 114(2):193-9. 69500
    View PubMed
68. Welsh PW, O'Connell EJ, Sachs MI, Moyer TP, Wick KA, Harrison LI, McCarville SE, Kvam DC. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals. Ann Allergy. 1989 May; 62(5):396-400. 1045254
    View PubMed
69. de Groen PC, McCallum DK, Moyer TP, Wiesner RH. Pharmacokinetics of cyclosporine in patients with primary biliary cirrhosis. Transplant Proc. 1988 Apr; 20(2 Suppl 2):509-11. 65380
    View PubMed
70. Moyer TP, Post GR, Sterioff S, Anderson CF. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood. Mayo Clin Proc. 1988 Mar; 63(3):241-7. 1044187
    View PubMed
71. Fleischer JE, Milde JH, Moyer TP, Michenfelder JD. Cerebral effects of high-dose midazolam and subsequent reversal with Ro 15-1788 in dogs. Anesthesiology. 1988 Feb; 68(2):234-42. 1042042
    View PubMed
72. Moyer TP, Palmen MA, Johnson P, Charlson JR, Ellefson PJ. Marijuana testing--how good is it? Mayo Clin Proc. 1987 May; 62(5):413-7. 1054720
    View PubMed
73. Post GR, Moyer TP, Anderson CF, Sterioff S. Long-term cyclosporine for renal allograft patients does not cause nephrotoxicity. Transplant Proc. 1987 Feb; 19(1 Pt 2):1761-3. 1040935
    View PubMed
74. National Academy of Clinical Biochemistry/ American Association for Clinical Chemistry Task Forceon Cyclosporine Monitoring. Critical issues in cyclosporine monitoring: Report of the task force on cyclosporine monitoring. Clin Chem. 1987; 33:1269-88. 1217441
    
75. McCarthy JT, Milliner DS, Kurtz SB, Johnson WJ, Moyer TP. Interpretation of serum aluminum values in dialysis patients. Am J Clin Pathol. 1986 Nov; 86(5):629-36. 59388
    View PubMed
76. Nixon DE, Moyer TP, Johnson P, McCall JT, Ness AB, Fjerstad WH, Wehde MB. Routine measurement of calcium, magnesium, copper, zinc, and iron in urine and serum by inductively coupled plasma emission spectroscopy. Clin Chem. 1986 Sep; 32(9):1660-5. 1052660
    View PubMed
77. Zachariah PK, Bloedow DC, Moyer TP, Sheps SG, Schirger A, Fealey RD. Pharmacodynamics of midodrine, an antihypotensive agent. Clinical Pharmacology & Therapeutics. 1986 May; 39(5):586-91. 58522
    View PubMed
78. Moyer TP, Johnson P, Faynor SM, Sterioff S. Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems. Clin Biochem. 1986 Apr; 19(2):83-9. 1051744
    View PubMed
79. Nixon DE, Moyer TP, Windebank AJ, Webster DD, Mussmann GV, McCall JT. Lack of correlation of low levels of whole blood and serum lead in humans. An experimental evaluation of this relationship in animals. Trace Substances in Environmental Health XIX: 1986; 248-256. 1052991
    
80. Moyer TP, Charlson JR, Ebnet LE. Improved chromatography of cyclosporine. Ther Drug Monit. 1986; 8(4):466-8. 1053147
    View PubMed
81. Sill JC, Nugent M, Moyer TP, Schaff H, Tinker JH. Plasma levels of beta-blocking drugs prior to coronary artery bypass surgery. Anesthesiology. 1985 Jan; 62(1):67-70. 54134
    View PubMed
82. Faynor SM, Moyer TP, Sterioff S, McDonald MW. Therapeutic drug monitoring of cyclosporine. Mayo Clin Proc. 1984 Aug; 59(8):571-2. 1119053
    View PubMed
83. Nugent M, Tinker JH, Moyer TP. Verapamil worsens rate of development and hemodynamic effects of acute hyperkalemia in halothane-anesthetized dogs: effects of calcium therapy. Anesthesiology. 1984 May; 60(5):435-9. 1120301
    View PubMed
84. Sill JC, Nugent M, Moyer TP, Torres LE, Schaff HV, Tinker JH. Influence of propranolol plasma levels on hemodynamics during coronary artery bypass surgery. Anesthesiology. 1984 May; 60(5):455-63. 51588
    View PubMed
85. Mastropaolo W, Holmes DR, Osborn MJ, Rooke J, Moyer TP. Improved liquid-chromatographic determination of mexiletine, an antiarrhythmic drug, in plasma. Clin Chem. 1984 Feb; 30(2):319-22. 50909
    View PubMed
86. Sedman AJ, Gal J, Mastropaolo W, Johnson P, Maloney JD, Moyer TP. Serum tocainide enantiomer concentrations in human subjects. Br J Clin Pharmacol. 1984 Jan; 17(1):113-5. 1120302
    View PubMed
87. McGoon MD, Seward JB, Vlietstra RE, Choo MH, Moyer TP, Reeder GS. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. Br Heart J. 1983 Dec; 50(6):579-85. 49887
    View PubMed
88. Moyer TP, Maruta T, Richelson E, Richardson JW. The implications for antidepressant therapy of measurement of urinary MHPG. Mayo Clin Proc. 1982 Oct; 57(10):665-7. 1114230
    View PubMed
89. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc. 1982 Sep; 14(3):605-9. 1114297
    View PubMed
90. Ducatman AM, Amundsen MA, Moyer TP. Case report: chronic nervous system disability-evaluation of the role of organophosphate pesticides. Am Assoc Clin Chem (Tdm - Therapeutic Drug Monitoring) 1982 Jul; 1-3. 1114741
    
91. Welch CL, Annesley TM, Luthra HS, Moyer TP. Liquid-chromatographic determination of zomepirac in serum and plasma. Clin Chem. 1982 Mar; 28(3):481-4. 47620
    View PubMed
92. Yao JK, Dyck PJ, VanLoon JA, Moyer TP. Free fatty acid composition of human and rat peripheral nerve. J Neurochem. 1981 Mar; 36(3):1211-8. 1111273
    View PubMed
93. Moertel CG, Ames MM, Kovach JS, Moyer TP, Rubin JR, Tinker JH. A pharmacologic and toxicological study of amygdalin. JAMA. 1981 Feb 13; 245(6):591-4. 1111213
    View PubMed
94. Ames MM, Moyer TP, Kovach JS, Moertel CG, Rubin J. Pharmacology of amygdalin (laetrile) in cancer patients. Cancer Chemotherapy & Pharmacology. 1981; 6(1):51-7. 1111765
    View PubMed
95. Moyer TP, Sheps SG. Antihypertensive agents: role of therapeutic drug monitoring. Ther Drug Monit. 1981; 3(3):217-30. 1112007
    View PubMed
96. Tisdall PA, Moyer TP, Anhalt JP. Liquid-chromatographic detection of thiazide diuretics in urine. Clin Chem. 1980 May; 26(6):702-6. 1110520
    View PubMed
97. Stote RM, Smith LH, Dubb JW, Moyer TP, Alexander F, Roth JL. Oxypurinol nephrolithiasis in regional enteritis secondary to allopurinol therapy. Ann Intern Med. 1980 Mar; 92(3):384-5. 1110521
    View PubMed
98. Anhalt JP, Moyer TP. The role of gas-liquid chromatography and liquid chromatography in therapeutic drug monitoring. Laboratory Medicine. 1980; 11:797-806. 1110522
    
99. Moyer TP, Fischer AG, Schulz AR. Kinetic studies on bovine thyroidal purine nucleoside phosphorylase. Int J Biochem. 1980; 11(3-4):243-50. 1110519
    View PubMed
100. Moyer TP, Jiang NS, Tyce GM, Sheps SG. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results. Clin Chem. 1979 Feb; 25(2):256-63. 1106999
     View PubMed
101. Muldoon SM, Tyce GM, Moyer TP, Rorie DK. Measurement of endogenous norepinephrine overflow from saphenous veins. Am J Physiol. 1979 Feb; 236:H263-H267. 1107111
     View PubMed
102. Moyer TP, Carpenter PC, Jiang NS, Machacek D. Series on clinical testing. 2. Fractionation of urinary ketosteroids: procedure and clinical significance. Mayo Clin Proc. 1978 Sep; 53:601-606. 35795
     View PubMed
103. Moyer TP, Jiang NS. Optimized isocratic conditions for analysis of catecholamines by high-performance reversed-phase paired-ion chromatography with amperometric detection. J Chromatogr. 1978 Jul 3; 153:365-372. 1105370
     
104. Lee H, Carlson JD, McMahon KK, Moyer TP, Fischer AG. Xanthine oxidase: a source of hydrogen peroxide in bovine thyroid glands. Life Sci. 1977 Feb 1; 20(3):453-8. 1104197
     View PubMed
105. Moyer TP, Fischer AG. Purification and characterization of a purine-nucleoside phosphorylase from bovine thyroid. Arch Biochem Biophys. 1976 Jun; 174(2):622-9. 1102583
     View PubMed